MedTrace Logo

A New Multi-parameter Neuromonitoring System to Save Patients' Lives in Stroke and Brain Injury

NCT01802762 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2017-09-06

No results posted yet for this study

Summary

To assess the feasibility of a new neuromonitoring system (NeMoSystem including NeMo Probe and NeMo Patch) and the accuracy of the measurement values (cerebral blood flow (CBF); cerebral blood volume (CBV)) obtained.

Conditions

  • Subarachnoid Hemorrhage
  • Optical Imaging

Interventions

DEVICE

NeMo Patch and NeMo Probe

A plaster based patch (NeMo Patch) and a combined probe for ICP monitoring and near infrared spectroscopy (NIRS) are applied as sensors. Data are collected by a NIRS instrument (NeMo Control Unit)

Sponsors & Collaborators

  • Medical University of Graz

    collaborator OTHER

  • University of Zurich

    collaborator OTHER

  • NeMoDevices AG

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2017-02-28
Completion
2017-05-31

Countries

  • Austria
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01802762 on ClinicalTrials.gov